ES395533A1 - Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico. - Google Patents

Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.

Info

Publication number: ES395533A1
Authority: ES; Spain
Prior art keywords: pharmaceutical compositions; sustained released; released pharmaceutical; sustained; polysiloxane
Prior art date: 1970-10-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES395533A

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Instituto de Angeli SpA

Original Assignee

Instituto de Angeli SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1970-10-09

Filing date

1971-09-29

Publication date

1974-10-16

1971-09-29 Application filed by Instituto de Angeli SpA filed Critical Instituto de Angeli SpA

1974-10-16 Publication of ES395533A1 publication Critical patent/ES395533A1/es

Status Expired legal-status Critical Current

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
230000002459 sustained effect Effects 0.000 title 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
229920003086 cellulose ether Polymers 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
-1 polysiloxane Polymers 0.000 abstract 1
229920001296 polysiloxane Polymers 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ES395533A 1970-10-09 1971-09-29 Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico. Expired ES395533A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB4816770A GB1357737A (en)	1970-10-09	1970-10-09	Sustained release pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
ES395533A1 true ES395533A1 (es)	1974-10-16

Family

ID=10447626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES395533A Expired ES395533A1 (es)	1970-10-09	1971-09-29	Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.

Country Status (8)

Country	Link
US (1)	US3853988A (es)
CA (1)	CA974883A (es)
DE (1)	DE2149699A1 (es)
DK (1)	DK129434B (es)
ES (1)	ES395533A1 (es)
FR (1)	FR2110314B1 (es)
GB (1)	GB1357737A (es)
SE (1)	SE382560B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS51123814A (en) *	1975-04-22	1976-10-28	Shin Etsu Chem Co Ltd	A process for preparing gradually releasable solid medicines
US4167558A (en)	1976-02-13	1979-09-11	Hoffmann-La Roche Inc.	Novel sustained release tablet formulations
DE2902414A1 (de) *	1979-01-23	1980-08-07	Hoechst Ag	Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
FR2514261B1 (fr) *	1981-10-08	1986-08-22	Aec Chim Organ Biolog	Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
DE3508097A1 (de) *	1984-07-21	1986-02-06	Hoechst Ag, 6230 Frankfurt	Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
FR2653338B1 (fr) *	1989-10-23	1994-06-10	Dow Corning Sa	Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
NZ282804A (en) *	1994-03-18	2000-12-22	Hans Jurgen Upmeyer	Use of dimethylpolysiloxane (dimeticone) for treating helicobacter pylori infections
DE4409357C2 (de) *	1994-03-18	1996-10-17	Upmeyer Hans Juergen	Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
US5965161A (en) *	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
AU6403196A (en) *	1995-06-30	1997-02-05	Baylor University	Polyester/carboxylic acid composite materials
US20110039807A1 (en) *	2009-08-13	2011-02-17	Kim Hyoung-Chun	Anti-parkinsonian compound acetylsalicylic acid maltol ester
CN104603194B (zh) *	2012-07-17	2017-11-24	陶氏环球技术有限责任公司	包含有机液体稀释剂和低粘度纤维素醚的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2805977A (en) *	1955-01-04	1957-09-10	Smith Kline French Lab	Sustained release pharmaceutical preparation
GB971486A (en) *	1960-04-01	1964-09-30	Rech S Pharma Et Scient	Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) *	1961-03-10	1964-05-19	Strong Cobb Arner Inc	Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) *	1962-05-01	1970-10-28	Smith, Kline & French Laboratories	Powdered silicone products and processes
IL26885A (en) *	1965-12-06	1970-10-30	Smith Kline French Lab	Pharmaceutical silicone compositions
US3518344A (en) *	1967-10-02	1970-06-30	Miles Lab	Tableting lubricant

1970
- 1970-10-09 GB GB4816770A patent/GB1357737A/en not_active Expired
1971
- 1971-09-28 CA CA123,851A patent/CA974883A/en not_active Expired
- 1971-09-28 US US00184634A patent/US3853988A/en not_active Expired - Lifetime
- 1971-09-29 ES ES395533A patent/ES395533A1/es not_active Expired
- 1971-10-04 FR FR7135618A patent/FR2110314B1/fr not_active Expired
- 1971-10-05 DE DE19712149699 patent/DE2149699A1/de active Pending
- 1971-10-07 DK DK487571AA patent/DK129434B/da unknown
- 1971-10-08 SE SE7112796A patent/SE382560B/xx unknown

Also Published As

Publication number	Publication date
CA974883A (en)	1975-09-23
FR2110314B1 (es)	1975-06-06
GB1357737A (en)	1974-06-26
DK129434B (da)	1974-10-14
DK129434C (es)	1975-03-10
SE382560B (sv)	1976-02-09
DE2149699A1 (de)	1972-04-13
US3853988A (en)	1974-12-10
FR2110314A1 (es)	1972-06-02

Publication	Publication Date	Title
ES403435A1 (es)	1975-05-01	Metodo para la preparacion de una composicion farmaceutica de liberacion lenta.
CA936472A (en)	1973-11-06	Formulation for sustained release of a biological agent
AU458705B2 (en)	1975-03-06	Improvements in or relating to pharmaceutical compositions
IL43839A0 (en)	1974-03-14	Compositions for sustained release of a medicament
AU3300571A (en)	1973-03-08	Pharmaceutical compositions
HK13377A (en)	1977-03-25	Pharmaceutical compositions
ES370058A1 (es)	1971-12-01	Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
CA974883A (en)	1975-09-23	Acetylsalicylic acid sustained release preparations
AU8251275A (en)	1975-09-04	Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
IL37013A (en)	1975-05-22	Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
PH12292A (en)	1978-12-29	7b-(d-5-amino-5-carboxyvaleramido)-7-methoxy-3-cephem 4-carboxylic acids and pharmacologically acceptable salts thereof and pharmaceutical compositions containing same
GB1126153A (en)	1968-09-05	Novel polygalacturonic acid derivative
BE764768A (fr)	1971-09-24	Compositions pharmaceutiques
CA958643A (en)	1974-12-03	Pharmaceutical compositions containing cyclobenzaprine
IL37139A0 (en)	1971-08-25	Triakoxybenzoyl aminoalkanoic acid derivatives and pharmaceutical compositions containing them
GB1373913A (en)	1974-11-13	Pharmaceutical compositions
CA981583A (en)	1976-01-13	Pharmaceutical compositions containing dantrolene sodium
ZA716461B (en)	1972-06-28	Pharmaceutical compositions
ZA718218B (en)	1972-08-30	New sulphonic acid esters,their preparation,and their medicinal use
AU445275B2 (en)	1974-01-23	Pharmaceutical compositions comprising phenoxy 2 aminopropanes
CA843403A (en)	1970-06-02	Sustained release medicinal tablets
AU465240B2 (en)	1975-09-25	Hypolifidemic pharmaceutical compositions containing diphenylalkane derivatives
IL37623A0 (en)	1971-11-29	Theophylline isobutyrate salts,their preparation and pharmaceutical compositions containing them
IL30297A0 (en)	1968-09-26	Bis-(p-chlorophenoxy)-acetic acid alkyl esters,their preparation and pharmaceutical compositions containing them
AU3210671A (en)	1973-02-08	Pharmaceutical compositions containing 4 hydroxynicotinic acid